Aβ-PETBiomarker1 paperHumans1LatestNov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 1Sep 2026: 0Oct 2026: 01Alzheimer's & DementiaHumans·30 AugLongitudinal plasma phosphorylated tau217 classification and the association with Alzheimer's disease progressionAlzheimer's diseaseGSA 2024 AbstractHumans·1 JanENABLING PRIORITIZATION FOR AMYLOID POSITIVITY TESTING WITH A DIGITAL COGNITIVE ASSESSMENTBiomarkersGSA 2024 AbstractIn silico·1 JanCOST EFFECTIVENESS ANALYSIS OF IMPLEMENTING A SCREENING PROGRAM FOR EARLY-STAGE ALZHEIMER’S DISEASE DETECTIONBiomarkersGSA 2024 AbstractIn silico·1 JanCOST EFFECTIVENESS ANALYSIS OF IMPLEMENTING A SCREENING PROGRAM FOR EARLY-STAGE ALZHEIMER’S DISEASE DETECTIONBiomarkersGSA 2024 AbstractHumans·1 JanENABLING PRIORITIZATION FOR AMYLOID POSITIVITY TESTING WITH DIGITAL COGNITIVE ASSESSMENTBiomarkers
Alzheimer's & DementiaHumans·30 AugLongitudinal plasma phosphorylated tau217 classification and the association with Alzheimer's disease progressionAlzheimer's disease
GSA 2024 AbstractHumans·1 JanENABLING PRIORITIZATION FOR AMYLOID POSITIVITY TESTING WITH A DIGITAL COGNITIVE ASSESSMENTBiomarkers
GSA 2024 AbstractIn silico·1 JanCOST EFFECTIVENESS ANALYSIS OF IMPLEMENTING A SCREENING PROGRAM FOR EARLY-STAGE ALZHEIMER’S DISEASE DETECTIONBiomarkers
GSA 2024 AbstractIn silico·1 JanCOST EFFECTIVENESS ANALYSIS OF IMPLEMENTING A SCREENING PROGRAM FOR EARLY-STAGE ALZHEIMER’S DISEASE DETECTIONBiomarkers
GSA 2024 AbstractHumans·1 JanENABLING PRIORITIZATION FOR AMYLOID POSITIVITY TESTING WITH DIGITAL COGNITIVE ASSESSMENTBiomarkers